← Search & browse all drugs
DERMATOLOGICALS › ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE › CHEMOTHERAPEUTICS FOR TOPICAL USE › Antivirals
berdazimer sodium
D06BB13
Adult Dosing
- Apply a thin layer to each lesion once daily until complete clearance
- Maximum duration of treatment: up to 12 weeks
- For cutaneous use only; not for oral, ophthalmic, or intravaginal use
Pediatric Dosing
- Approved for pediatric patients aged 1 year and older
- Apply a thin layer to each lesion once daily until complete clearance (up to 12 weeks)
Indications
- Treatment of molluscum contagiosum in adults and pediatric patients aged 1 year and older
Mechanism of Action
- Nitric oxide (NO) releaser that penetrates the skin and exerts antiviral and immunomodulatory effects to clear molluscum contagiosum lesions
Contraindications
- History of hypersensitivity to berdazimer or any components of the formulation
Adverse Reactions
- Application site pain
- Application site erythema
- Application site pruritus
- Application site dermatitis
- Application site erosion
Drug Interactions
- No formal drug-interaction studies have been conducted
- Avoid simultaneous application of other topical products on the same treatment areas
Curated Content: Needs Vetting Before Put to Clinical Use